| 
			
			 The testimony in a state court in Norman, Oklahoma, came during the 
			first trial to result from around 2,000 lawsuits by state and local 
			governments against opioid manufacturers. 
 Those cases seek to hold the companies responsible for an epidemic 
			the U.S. Centers for Disease Control and Prevention says led to a 
			record 47,600 opioid-related overdose deaths in 2017.
 
 Holding back tears, Craig Box said he never suspected his son 
			Austin, a 22-year-old University of Oklahoma linebacker, was abusing 
			painkillers until after the young man was found unconscious at a 
			friend's house in 2011 and died at a hospital.
 
 "We had no idea about the prevalence of these drugs and the dangers 
			of these drugs," Box said during testimony streamed online by 
			Courtroom View Network.
 
			
			 
			Box, who said he did not know what painkillers his son took, was 
			called as a witness to support Oklahoma Attorney General Mike 
			Hunter's assertion that J&J helped cause the epidemic by marketing 
			opioids as safe and effective for everyday pain while downplaying 
			their addictive qualities.
 Oklahoma resolved similar claims against OxyContin maker Purdue 
			Pharma LP in March for $270 million and against Teva Pharmaceutical 
			Industries Ltd on Sunday for $85 million.
 
 The state in the nonjury trial before Judge Thad Balkman has argued 
			J&J's actions created an oversupply of painkillers and a public 
			nuisance that will cost $17.5 billion to remedy over 30 years.
 
			
            [to top of second column] | 
            
			 
			J&J denies wrongdoing, arguing it properly marketed opioids and that 
			the state cannot prove it caused the epidemic. Its stock price 
			closed 4.2% lower at $131.33 on Wednesday.
 To support their claims, the state's lawyers played a videotaped 
			deposition from Dr. Russell Portenoy, a physician who spent years 
			advocating the use of opioids for chronic pain while acting as a 
			paid speaker and consultant for drugmakers like J&J.
 
 Portenoy, who agreed to testify for Oklahoma to avoid being sued 
			himself, said he was troubled by how drugmakers used his writings 
			and left out "balance" regarding opioids' risks.
 
 "I've come to conclude their conduct in marketing without context, 
			without education, without risk, produced an increase in 
			inappropriate and unsafe prescribing that contributed to the public 
			health crisis," he said.
 
 (Reporting by Nate Raymond in Boston; Editing by Bill Berkrot and 
			Jonathan Oatis)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			
			 |